The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

 BioCryst Pharmaceuticals Inc  (BCRX) Trade Now »     Rate BCRX  -  Discuss BCRX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
45.0%
Top:
0.0%
Rate BCRX:



Who've Rated BCRX All   |   Bullish   |   Bearish   |   Hold

Name Rank Rating Return Start Closed
Obi-wankenobi_main
mbmalone N/A Positive -65.30% 10/30/09 --
Mikerun
Mike Havrilla 73% Negative +64.05% 10/29/09 --
scottlee N/A Positive -64.13% 08/02/09 --
titor N/A Positive -69.42% 07/27/09 --
onetime969 N/A Positive -65.23% 07/27/09 --
roby1050 N/A Positive -46.17% 07/21/09 --
Cambo Nguyen N/A Positive -26.99% 06/11/09 --
mendigo N/A Negative +10.57% 05/23/09 --
costass2 84% Positive +135.71% 03/13/09 --
costass2 84% Positive +0.00% 03/13/09 03/13/09
Graeme Smith 53% Negative +43.97% 12/28/07 --
Graeme Smith 53% Negative +0.00% 12/28/07 12/28/07
Samir J 37% Positive -57.64% 06/30/07 --


ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on BCRX

Visit streetinsider.com


Discussion Wall + Add  

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   23 replies

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About BioCryst Pharmaceuticals Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch